Charles River Labs Intl buy Bank of America Co.
Start price
15.12.25
/
50%
€168.60
Target price
15.12.26
€191.66
Performance (%)
43.06%
Price
18.08.26
€241.20
Summary
This prediction is currently active. With a performance of 43.06% the BUY prediction by Bank_of_America_Co_ is a big success. This prediction currently runs until 15.12.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Charles River Labs Intl | -1.309% | -1.309% |
| iShares Core DAX® | -0,87 % | 5,32 % |
| iShares Nasdaq 100 | -0,38 % | 1,98 % |
| iShares Nikkei 225® | -1,68 % | 1,95 % |
| iShares S&P 500 | -0,65 % | 2,07 % |
Comments by Bank_of_America_Co_ for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International (NYSE:CRL) was upgraded by analysts at Bank of America Corporation from a "neutral" rating to a "buy" rating. They now have a $225.00 price target on the stock.
Ratings data for CRL provided by MarketBeat

